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Background: Tuberculosis accounted for 8.7 million new cases in 2011 and continues to be one of the leading
human infectious diseases. Burdensome is the increasing rate of multi-drug resistant tuberculosis (MDRTB) and the
difficulties created for treatment and public health control programs, especially in developing countries. Resistance
to rifampicin (RIF), a first line antibiotic, is commonly associated with point mutations within the rpoB gene of
Mycobacterium tuberculosis (Mtb) whose detection is considered the best early molecular predictor for MDRTB.
Gold nanoparticles functionalized with thiol-modified oligonucleotides (Au-nanoprobes) have shown the potential
to provide a rapid and sensitive detection method for Mtb and single base alterations associated with antibiotic
resistance, namely in rpoB gene associated to RIF resistance.
Results: We developed a strategy based on the isothermal amplification of sample DNA (LAMP) coupled to specific
Au-nanoprobes capable of identifying members of the Mtb complex (MTBC) and discriminating specific mutations
within the rpoB gene. Integration of LAMP and Au-nanoprobe assay allowed to detect MTBC member and identify
mutations linked to RIF resistance. A total of 12 biological samples were tested and a 100% specificity and sensitivity
was attained.
Conclusions: There is an increasing demand for simple, fast and cheap methods for the molecular identification of
Mtb and for the detection of molecular tags associated to drug resistance suitable for use at point-of-need. Here we
describe such a method, that as the potential to get molecular diagnostic of tuberculosis to remote environments.
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RifampicinBackground
Tuberculosis (TB) is still one of the leading human
infectious diseases with reports of 8.7 million new cases
in 2011 [1]. Amongst these, of particular concern is the
increasing rate of antibiotic resistance, namely for first line
antibiotics, such as Rifampicin (RIF) [1]. The emergence
of drug resistant M. tuberculosis poses a serious threat to
the TB control programs and the TB cure rates since* Correspondence: pmvb@fct.unl.pt
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stated.patients infected with drug resistance strains are difficult
to treat and are likely to remain as sources of infection
for longer periods of time. Resistance to RIF has been
associated to single point alterations within a well-defined
81 bp region (codons 507–533) of the rpoB gene encoding
for the beta subunit of RNA polymerase [2,3]. More than
35 distinct single base mutations have been described
within this region conferring resistance to RIF and among
these, two mutations - H526D and S531L - account for
two-thirds of RIF resistance and are absent in susceptible
isolates, making them ideal molecular tags for detection
strategies [2-4]. Access to point-of-need diagnostics in TB
is the greatest obstacle for the early detection andLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
Figure 1 Au-nanoprobe strategy for detection of MTBC members and mutations associated with RIF resistance. Illustration of the LAMP
amplification using primers specific for MTBC members and schematic representation of the rpoB gene and positions of primers and probes.
Au-nanoprobe detection strategy of LAMP products (MTBC probe) and rpoB S531L mutation: The black box indicates the sequence recognized by
the MTBC-probe. The dashed box with corresponds to the sequence recognized by the mutation specific probes derived from the rpoB gene.
The colorimetric assay consists of visual comparison of test solutions before and after salt induced Au-nanoprobe aggregation.
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standard methods of diagnostic are either, cumbersome
and expensive, or only exist at centralized laboratories.
Most proposed systems thus far rely on the PCR amplifi-
cation of the sample before detection [3,5]. Therefore, the
development of cheap, fast and simple molecular methodsto assess susceptibility profiles at point-of-care would
have a huge impact in the capacity of early diagnosis
and treatment of TB patients.
We have previously reported on a colorimetric non-
cross-linking approach using gold nanoparticles (AuNPs)
functionalized with thiol-modified DNA (Au-nanoprobes)
Table 1 LAMP primers and Au-nanoprobes sequences
Name Sequence
rpoB BIP 5’ CCG GCG GTC TGT CAC GTG AAG TGC GAC
GGG TGC A 3’
rpoB FIP 5’ TGG GTG GTC ATC CGC TCC CCA GAT
CCG GGT CGG CAT G 3’
rpoB F3 5’ TCG GCG AGC TGA TCC AA 3’
rpoB B3 5’ CCC CTC AGG GGT TTC GA 3’
MTBC Thiol - 5’ GAT CGC CTC CAC GTC C 3’
rpoB 531 WT Thiol - 5’ GCC GAC AGT CGG CGC TTG TG 3’
rpoB 531 Mut Thiol - 5’ GCC GAC AGT CGG CGC TTG TC 3’
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mutations [6-8]. This approach is based on the different
aggregation profile of Au-nanoprobes in presence/absence
of the specific complementary target upon salt induced
nanoparticle aggregation. Presence of the complementary
target sequence to that of the probe prevents aggregation
and the solution remains red (localized surface plasmon
resonance (LSPR) band at 525 nm), whereas absence of a
specific target sequence leads to extensive aggregation
after salt addition and the solution turns blue (red-shift of
the LSPR peak). The system is extremely sensitive and
allows detection of the pathogen’s DNA directly from
biological samples [9]. However, for robustness and
detection of single base alterations, a PCR amplification
step is usually required.
Here, we overcome the need for PCR by coupling the
Au-nanoprobe detection protocol to Loop-mediated
isothermal amplification (LAMP) – see Figure 1. The
use of LAMP for sample DNA amplification seems to
be ideal for field analysis as its isothermal profile, increased
specificity and speed, make this approach desirable over
standard PCR, especially for point-of-need application [10].
Taking advantage of such features, we demonstrate that the
non-cross-linking system is capable to discriminate the
rpoB S531L point mutation on LAMP products and, thus,
opening new possibilities for MDRTB diagnostics in remote
environments and at a point-of-care.
Methods
All reagents were purchased from Sigma Aldrich and were
of analytical grade. HPLC purified labeled oligonucleotides
were purchased from STABVida (Portugal) and used
without further purification. Thiolated oligonucleotides
were used to synthesize the Au-nanoprobes and non-
modified oligonucleotides were used as controls for
calibration of the assay.
Twenty-five clinical isolates obtained from respiratory
samples positive for acid fast bacilli from patients of
the Lisbon Health Region, including 6 strains susceptible
and 6 resistant to RIF, were used. Additionally, one strain
previously determined as Mtb H37Rv (ATCC27294T)
was used as positive control and a non-MTBC strain
(M. kansasii) as negative control. The BACTECTM
MGITTM 960 (BACTEC 960) system was used for
primary isolation and standard susceptibility testing
for the first line drugs (streptomycin, isoniazid, RIF
and ethambutol) according to the manufacturer’s instruc-
tions (Becton Dickinson Diagnostic Systems, Sparks, MD,
USA). Identification of MTBC and mutations in the rpoB
gene associated to RIF resistance was performed by
INNO-LiPA Rif. TB assay (Innogenetics, Belgium). DNA
was extracted from cultures with the QIAamp DNA
Mini kit (QIAGEN, Hilden, Germany) according to the
manufacturer’s instructions.LAMP amplification and primer design were performed
according to Notomi et al. [10] (see Table 1). Reactions
were performed in a final volume of 50 μl including 1 μM
of each inner primer FIP and BIP, 0.1 μM of each outer
primer FP and BP, 0.3 mM of dNTP mix, 1× of the
supplied buffer, 0.5 M betaine (Sigma–Aldrich, MO, USA),
2 mM MgCl2, and 10 ng of DNA. An initial step of 10 min
denaturation at 95°C on a Bio-Rad MyCycler Thermocycler
(BioRad, CA, USA) was performed and afterwards the
mix was cooled down at 4°C for one minute. Following
addition of 1U of Bst DNA polymerase, large fragment
(New England Biolabs Inc., MA, USA), the reaction
mixture was incubated for 30 min at 65°C. For the
negative control, the same procedure was followed
but sample DNA was substituted by water. Following
LAMP, all samples were ethanol precipitated and
centrifuged for 15 min at 14000 g, the pellet dried
under vacuum and resuspended in sterile deionized
water.
Au-nanoprobes sequences were designed using Serial
Cloner v. 1.3-11 and BioEdit 7.1.3.0 comparative tools
aligning the probe sequence with the target M. tuberculosis
gene. The Au-nanoprobe set for mutation detection con-
sisted of two probes (see Table 1): one complementary to
the wild type (WT) sequence and the other complementary
to the mutated (Mut) sequence. AuNPs, with an average
diameter of ~14 nm, were synthesized (see Additional file 1:
Figure S1) and functionalized as described by Veigas et al.
[7]. Briefly, AuNPs (15 nM) were mixed with thiol-modified
oligonucleotides in a theoretical ratio of 1:200 AuNPs:oligo,
thus increasing salt solutions were added in 20 min
intervals to attain a final NaCl concentration of 0.3 M in
order to reduce non-specific bonds between the thiol-
modified oligonucleotides and the AuNPs. The solution
was incubated during 16 hours and washed with 10 mM
phosphate buffer (pH 8). The solution was centrifuged, the
resulting pellet resuspended in 10 mM phosphate buffer
(pH 8), 0.1 M NaCl, and stored in the dark at 4°C till
further use. The minimum amount of salt (MgCl2) required
to induce aggregation of the Au-nanoprobe in absence of
Figure 2 LAMP products tested with rpoB probe set. Au-nanoprobes detection assays of LAMP products, using the Abs525nm\Abs600nm ratio of
rpoB 531 WT probe divided by the ratio of rpoB Mut probe. Values higher than one are considered WT (Black) and lower than one Mut (White).
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for each synthesized probe (see Additional file 1: Figure S2).
The Au-nanoprobe colorimetric assays were performed
in a final volume of 30 μl containing Au-nanoprobes at a
final concentration of 2.5 nM in 10 mM phosphate buffer
(pH 8) and the LAMP DNA product at a concentration
of ~30 ng/μL. The mixture was heated up at 95°C for
10 min and then cooled down to 20°C for 10 min. For each
probe, the assay consisted on the spectrophotometric com-
parison of a “Blank” (without DNA), 10 mM phosphate
buffer (pH 8), 0.1 M NaCl; POSITIVE control containing
a complementary control DNA to the Au-nanoprobe;Figure 3 LAMP products tested with MTBC probe. PC - positive contro
between positive (Black) and negative (Grey).a NEGATIVE control containing non-complementary
DNA; and the samples. The pre-determined MgCl2 amount
was added to each reaction and, after 30 min at room
temperature for color development, the mixtures and the
blank assayed by UV/visible spectroscopy in a microplate
reader (Tecan Infinite M200). For calibration purposes,
each set of Au-nanoprobes was tested against purified
simplex PCR amplicons.
Aggregation profiles were analyzed in terms of the
Abs525nm/Abs600nm ratio (dispersed vs. aggregated species)
for each Au-nanoprobe. A minimum of three independent
assays were performed for each sample and a threshold ofl; NC - negative control. A threshold of 1 was set to differentiate
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Au-nanoprobes, whereas a value <1 indicates aggregation
[11]. For the MTBC Au-nanoprobe, this approach provides
for indication of presence or absence of MTBC DNA in the
sample, respectively. When using a set of Au-nanoprobes
targeting the WT and Mut sequences, and to simplify
analysis, the Abs525nm/Abs600nm ratio for the WT probe
was divided by the ratio of the Mut prob. Values >1
identify cases where the WT probe is more stable
than Mut probe, and thus the sample presented the
WT sequence; whereas values <1 indicate the pres-
ence of mutation. For every sample, a minimum of
three independent tests were performed and the mean
value used.
Results and discussion
LAMP primers were designed to amplify one of the most
relevant loci for characterization of mutations associated
with RIF resistance – rpoB. A single cut restriction
enzyme followed by agarose gel electrophoretic analysis
was used to confirm amplification of the desired amplicon
(see Additional file 1: Figure S3). Since LAMP amplification
does not rely on temperature cycles, faster amplification
than standard PCR protocol for the target sequence is
attained [12]. Then, 12 samples previously characterized for
molecular signatures of susceptibility were successfully
amplified by LAMP.
An Au-nanoprobe capable of identifying members of
MTBC was synthesized and calibrated using synthetic
oligos. LAMP products were then assayed with the
MTBC Au-nanoprobe and all 12 samples were accurately
scored as MTBC positive – see Figure 2. The additional
Au-nanoprobe set, specific for one of the most common
point mutations associated with RIF resistance (rpoB S531L),
was also synthesized. This set is composed of two probes:
one complementary to the WT sequence and the
other complementary to the mutation, where each probe
sequence was designed so as to be complementary to the
target sequence with the possible mutation at the 3´ end
of the Au-nanoprobe for better sequence discrimination
[13]. All 12 samples amplified by LAMP were assessed
with this Au-nanoprobe set, which was capable to cor-
rectly identify the genotype present with a specificity
and sensitivity of 100%. Figure 3 shows that from 12
samples 6 were characterized as rpoB 531 WT and
the other 6 as rpoB S531L (see also Additional file 1:
Table S4).
We report on the development of an isothermal ampli-
fication coupled to Au-nanoprobe detection protocol for
the simultaneous detection of members of MTBC and
characterization of mutations associated with antibiotic
resistance in M. tuberculosis. For the first time, it was
possible to identify single point mutations on LAMP
products via the use of Au-nanoprobes. Since LAMPoriginates long DNA concatemers, we demonstrate that
Au-nanoprobes are capable to discriminate single base
mismatches independently of DNA length and only
dependent of differential hybridization WT and Mut
Au-nanoprobes to the target DNA sequence.
We demonstrate that it is possible to use an Au-
nanoprobe based strategy to detect single point alteration
on isothermally amplified DNA products. Previous work of
a colorimetric detection approach using Au-nanoprobes
coupled to LAMP has been described [14-16], however
this is the first time this approach is described for
the identification of point mutations with biological
samples. We further demonstrate that this method is
highly specific for application to real biological samples.
The LAMP-Au-nanoprobe strategy was capable to specif-
ically identify MTBC members and mutations associated
to RIF resistance in Mtb within 90 minutes of DNA
extraction. Our technique has proven to be a fast and
robust approach, ideal for the molecular diagnostic at
point-of-need. The Au-nanoprobes strategy discards the
use of electrophoretic analysis of LAMP products thus
speeding the results and reducing costs; it also as the
possibility to be extended, to analyze more mutation
with a single LAMP. Future work will be focused on
the optimization of this strategy towards assessment
of other mutations associated with MDRTB.
Additional file
Additional file 1: Characterization of AuNPs, Au-nanoprobes and
LAMP products. Additional figures of AuNPs, Au-nanoprobes and LAMP
products characterization: TEM analysis of AuNPs, with nanoparticle
counts and TEM image; effect of salt in the stability of Au-nanoprobes;
electrophoretic analysis of LAMP product.
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